Efficacy of treatment with chimeric monoclonal antibody (Infliximab) to tumor necrosis factor-alpha for Crohn's disease in Japan: evaluation by rapid turnover proteins, and radiologic and endoscopic findings.
J Gastroenterol Hepatol
; 16(7): 763-9, 2001 Jul.
Article
in En
| MEDLINE
| ID: mdl-11446884
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Gastrointestinal Agents
/
Crohn Disease
/
Tumor Necrosis Factor-alpha
/
Antibodies, Monoclonal
Type of study:
Clinical_trials
/
Diagnostic_studies
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Asia
Language:
En
Journal:
J Gastroenterol Hepatol
Year:
2001
Document type:
Article